I'm trying to get a handle on a very slippery timeline. My
I'm trying to get a handle on a very slippery timeline. My guess timeline is 2 to 5 years. Can anyone venture an educated guess on settlement with Amarex or parent company. I ask only because from my past experience they can outlast us simply by delaying the process and make us run out of money. GE did it to Tesla and got the patents on AC to boot and it's not that hard to do if you have staying power. I would like to hear from anyone with legal background or prior experience in these type of litigation's.
We have limited time and money raising opportunities at this point. Getting a partner or approval may save us but if it doesn't happen within this year, my personal timeline of this molecule being a success with Cytodyn seems to go into reverse mode. I have been an avid supporter for 4 years now and have invested way over my allotment because of Nader and possible my nature of being a chance taker in the bio market. Knowing this economy is going to continually punish companies with negative earnings going forward for possibly the next 2 years even if they have a great story, is partially my reasoning for this musing. Earnings seems to be the key and the company has to somehow make that happen. Even if it means making deals that seem fortuitous to the larger company for the time being, I think it is the way forward. Continually selling stock has kept the doors open but at some point real soon, it will make the company worthless, especially to older shareholders who can't keep putting money into lower their SP when there can be potentially a billion shares out there and an extending timeline.
I'm not raising a red flag, more of a warning shot to the mgmt...make a deal before the ship runs aground and we all scatter like roaches to the next greatest thing with our tails between our legs and a very expensive lesson.
Is this next announcement important? you bet your ass it is! The reason Cytodyn has not updated us is...they have no concrete info that will move the SP positively and know it. They understood salesman speak has worn out everyone and pure definable results are the only meter to go by. The results next week will determine to a large extent if a breath of hope is there to partner in my estimation. The molecule has many optimistic areas of research but few takers. That almost always means the large companies that are interested are waiting like vultures and will do all they can to make sure it comes within millimeters of death before swooping down to scoop it up at nothing prices. They obviously don't have confidence that the mgmt can steer the company long enough to win the war and are content to let them flounder until they die (knowing they have a partner in the FDA with their foot on our neck) and take many of us investors down with them. This intern allows their competing drugs to flourish while ours dies. It's a win win for the acquiring company. Unfortunately I have seen this in a few investments throughout my years and am starting to see the writing on the wall once again. I am hoping next week brings not only good factual results that blow away the competition but also a partnership announcement. Sorry for the long disjointed post but almost $1,000,000 invested and peanuts to show has made me active and short tempered to say the least.
Ok, I'm done for the year. Moderators, you may delete this post but I felt the need to get it out. Whew!
12
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Slashing Rates to Keep Customers Happy Staring down utility bills isn't anyone's favorite pastime, but there's some good news for folks under Duke Energy Florida's wings. Come January 2027, customers throughout the Sunshine State are in for a surprise on their electricity bills—lower numbers! A $33 slash in the typical residential power bill could be just around the...
Continue Reading
When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...
Continue Reading
Election Day rolled in like a wild card, with markets doing their dance that makes seasoned traders either groan or grin. This time, Tuesday saw the Dow slipping while the Nasdaq climbed higher, reflecting a split personality kind of session. Ain't it funny how one day can hold such different tales depending on which index gets your focus? Indices' Dance: Dow Down, Nasdaq...
Continue Reading
Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...
Continue Reading
Lululemon Faces a Legal Storm If you're holding shares in Lululemon (NASDAQ: LULU), you might want to sit up and pay attention. Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, is gathering folks for a securities fraud class action lawsuit against Lululemon. They're pointing fingers at the company for cooking the books – or at least not being...
Continue Reading
The Case for Invisible Fences Man's best friend meets modern containment! Why are hidden fences gaining traction in households across Culpeper, VA, and beyond? Pet Containment Expert Lawrence Sowers spills some valuable insights into why so many are ditching traditional fences. Practical reasons abound, folks! Keeping the Yard Beautiful Who wants their landscaping ruined...
Continue Reading
Steering Parkview into New Waters Every now and then, a company gets a leader who feels like a tailor-made fit for its ambitions. Parkview Dental Partners just scored big with Jon Gregoire taking the helm as CEO. Gregoire, a seasoned DSO bigwig with a knack for M&A, is set to power up the gears for Parkview’s next growth spurt. We're talking about a guy who knows the...
Continue Reading
WuXi Strikes Gold with ESG Distinction Take a look under the hood, and you’ll find that WuXi Biologics (2269.HK) isn’t just playing the long game—they’re redefining it. They’ve clinched not one, but two prestigious honors from the Hong Kong ESG Reporting Awards (HERA). And with sustainability in the hot seat worldwide, these wins are no small potatoes. They...
Continue Reading
Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...
Continue Reading
A Glimpse into Saudi's Ambitious Tourism Drive Ever feel like someone just decided to dominate the conversation at a global pow-wow? Well, that's the vibe Saudi Arabia brought to the World Travel Market (WTM) in London for 2026. With His Excellency Ahmed Al-Khateeb making headlines together with a mighty entourage of 37 tourism partners, the message was clear: Saudi...
Continue Reading
Top 5 Most Recently Viewed Articles
Quimbaya Gold's Strategic Financing Update Quimbaya Gold Inc. (CSE: QIM) has recently taken a bold step, amplifying its bought deal financing to a remarkable $12.5 million. This decision comes in response to significant investor demand, showcasing the market's confidence in Quimbaya's prospects. The company has partnered with Stifel Canada, which will serve as the sole...
Continue Reading
Doehler Dry Ingredient Solutions, LLC's Recall Announcement Doehler Dry Ingredient Solutions, LLC has announced the recall of the Member's Mark Freeze Dried Fruit Variety Pack. This recall involves the 15 count boxes, UPC 1 93968 50900 2, which were distributed to various retail locations, making them a concern for many consumers. This action is being taken due to...
Continue Reading
Archbishop Sample's Pastoral Teaching on Life In a heartfelt response to recent proclamations regarding abortion, Archbishop Alexander K. Sample has issued a Pastoral Teaching that reverberates with compassion and commitment to the sanctity of life. His powerful message emerges against a backdrop of growing cultural acceptance of practices that he perceives as detrimental...
Continue Reading
Driving Fans Closer to the Fast Lane Right out of the gate, Velo and McLaren are pulling drama off the tarmac, turning F1 into a full-throttle affair of the heart. They've relaunched the 'Live Your Fandom' initiative, reminding us that being a fan isn't just about belting cheers from the bleachers. It's an art of living. They want supporters electrified, shouting their...
Continue Reading
Interra Copper Begins Phase One Drilling Program Interra Copper Corp. has officially kicked off its Phase One drilling initiative at the RIP Copper Project, located in the Stikine region of British Columbia. This project signifies an exciting opportunity for the company, as it stands around 33 kilometers northeast of a previously operating copper-molybdenum mine. The...
Continue Reading